MTS Medical

dermagold100 - first shockwave therapy system approved for skin lesions

MTS Europe GmbH and its partner, Tissue Regeneration Technologies, LLC. (TRT), are pioneers in the field of tissue regeneration. This partnership enables us to reach new milestones in our exploration of novel treatment methods in the field of dermatology. The Dermagold revolutionizes the treatment of chronic wounds and skin lesions by utilizing the biological effect of shock waves. The full potential of shock wave therapy is to date unknown, but MTS and TRT are on the cutting edge of research and development in this exciting field.

News

Meet us at :

Düsseldorf, 17-20 November 2010
Medica 2010, Booth 16C41

Chicago, 24-26 June 2010
13th ISMST Congress

Madrid, 2-5 June 2010
11th EFORT Congress

Dubai, 25-28 January 2010
Arab Health, Booth ZB18